SINSIN PHARMACEUTICAL Co., LTD.

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band A with a total score of 68.4 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

Upper percentile

Top 8.3% in sector — P/E (price-to-earnings)Price attractiveness →Top 8.7% in sector — ROE (return on equity)Financial strength →Top 13.3% in sector — Dividend yieldShareholder Return →

Lower percentile

Bottom 23.7% in sector — Current ratioFinancial strength →

1-year closing price

Low ₩4,015High ₩6,630

Latest close

Price change by period

7.00%

13.50%

2.60%

15.90%

As of the Sep 1, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

Financial strength

56.7/100

How much debt does it carry relative to equity?

84.5%

Sector median 51.6%

Sector low

highBottom 31.8% in sector

Can it cover what's due within a year?

98.4%

Sector median 191.7%

Sector low

highBottom 23.7% in sector

How much of revenue becomes profit?

9.5%

Sector median -2.4%

Sector low

highTop 19.9% in sector

How much did it earn on its own capital?

12.4%

Sector median -4.5%

Sector low

highTop 8.7% in sector

Source filing: annual report (consolidated) — view original ↗

Growth momentum

68.7/100

How much did revenue grow in a year?

6.9%

Sector median 6.4%

Sector low

highTop 47% in sector

Has it grown steadily over three years?

7.4%

Sector median 4.9%

Sector low

highTop 42% in sector

Did core profits grow in a year?

56.6%

Sector median 3.6%

Sector low

highTop 18.4% in sector

Are core profits higher than three years ago?

98.9%

Sector median 3.5%

Sector low

highTop 18% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

78.8/100

Is the price expensive relative to earnings?

7.7x

Sector median P/E of profitable peers 16.3x · 58% loss-making

Sector low

highTop 8.3% in sector

Is the price expensive relative to book value?

0.95x

Sector median 1.61x

Sector low

highTop 34.2% in sector

Valuation uses the Sep 1, 2026 close and market cap

Shareholder Return

Single-indicator axis86.7/100

Does the company actually pay dividends?

1.4%

Sector median 0.0%

Sector low

highTop 13.3% in sector

Dividend per share (annual)

Cash dividend per common share as stated in annual reports. ₩0 means no dividend that year.

Dividends & treasury shares

Total cash dividends (FY2025): ₩1.2B
Cash payout ratio, consolidated (FY2025): 13.1%

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (consolidated) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 8 met · 1 not met · 0 not computable

Not metMetNot computable

Positive net income

Whether net income (attributable to owners where available) is above zero.

Met

₩9.3B

Positive operating cash flow

Whether cash flow from operations is above zero.

Met

₩8.6B

Return on assets up

Whether net income over beginning total assets rose from the prior year.

Met

3.9% → 7.2%

Operating cash flow exceeds net income

Whether operating cash flow is greater than net income.

Not met

₩8.6B vs ₩9.3B

Liabilities-to-assets ratio down

Whether total liabilities as a share of total assets fell from the prior year.

Met

49.4% → 45.8%

Current ratio up

Whether current assets over current liabilities rose from the prior year.

Met

87.1% → 98.4%

Shares outstanding not increased

Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.

Met

15,170,500 → 15,170,500

Operating margin up

Whether operating income over revenue rose from the prior year.

Met

6.5% → 9.5%

Asset turnover up

Whether revenue over beginning total assets rose from the prior year.

Met

0.86x → 0.88x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original ↗

Grade change history

Jul 23, 2026A

Methodology version change (v2.0 applied)

Jul 15, 2026AVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Position within sector

1-year closing price

Financial strength

Growth momentum

Financial trend

Revenue

Growth & margin

Year over year — alongside the sector median

Price attractiveness

Shareholder Return

Dividend per share (annual)

Dividends & treasury shares

Financial checklist

Grade change history

Recent filings for this stock